Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812318 · ClinicalTrials.gov registry record · Phase 1
Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
A Phase 1 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT00812318 is a Phase 1 study that has completed, run by ViiV Healthcare. The registered enrollment target is 45 participants.
The verdict
NCT00812318, a Phase 1 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
To evaluate the single dose relative bioavailability of GSK1265744 10mg administered in either oral solution fasted, two 5mg tablets fasted, or two 5mg tablets following a moderate meal.
Interventions
- DRUG GSK1265744 10 mg oral solution
- DRUG GSK1265744 5 mg tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812318
The ClinicalTrials.gov registry entry for NCT00812318 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GSK1265744 10 mg oral solution is the first listed.
NCT00812318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812318 about?
NCT00812318 is a clinical study titled "Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.". To evaluate the single dose relative bioavailability of GSK1265744 10mg administered in either oral solution fasted, two 5mg tablets fasted, or two 5mg tablets following a moderate meal.
What is the current status of trial NCT00812318?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2008-06. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00812318?
The interventions under investigation include: GSK1265744 10 mg oral solution (DRUG), GSK1265744 5 mg tablet (DRUG).
Who is sponsoring clinical trial NCT00812318?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.